Client LoginSend a Press Release
CourierPR

Desks

779 releases · Page 11

Health & Medicine

Latest press releases filed to this category.

Model N ·

Model N Survey Shows 35% Delay Prescriptions Due to Uncertain Costs

REDWOOD CITY, Calif. -- In a new survey conducted by Model N, a leading end-to-end commercialization, revenue optimization, and compliance platform for life sciences companies, nearly one in three U.S. adults (35%) reported that not knowing …

Bronte Wellness Boutique ·

Bronte Wellness Boutique Offers Comprehensive Women's Health Care

Women's health is rarely about one symptom, one hormone, or one stage of life. Changes in energy, sleep, weight, mood, metabolism, digestion, skin, thyroid function, stress, and hormonal health often overlap, and understanding how those pieces fit together can make …

SOTIO Biotech ·

SOTIO Advances SOT106 with FDA Designations

PRAGUE and BASEL, Switzerland and BOSTON -- PRAGUE and BASEL, Switzerland and BOSTON, Sept. 23, 2026 /CourierPR/ -- SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced that the U.S. Food and Drug Administration has granted SOT106 Orphan Drug Designation for the treatment of …

Dr. Rod J. Rohrich, M.D., F.A.C.S ·

Dr. Rohrich Named Top U.S. Plastic Surgeons for Six Years

DALLAS -- Dallas Plastic Surgeon Dr. Rod J. Rohrich has been ranked as the top plastic surgeon in the United States for six consecutive years, according to Newsweek's America's Best Plastic Surgeons 2026 rankings. Dr. Rohrich …

Artiva Biotherapeutics ·

Artiva Biotherapeutics to Present AlloNK® Data at ISSjD 2026

SAN DIEGO -- Artiva Biotherapeutics, a clinical-stage biotechnology company based in San Diego, California, announced that it will present updated clinical data on its AlloNK® (also known as AB-101) therapy at the 17th International Symposium on …

Always Best Care ·

Always Best Care Launches in Round Rock for Senior Care Services

ROUND ROCK, Texas -- Tarun and Kokil Singhal have launched Always Best Care Senior Services of Round Rock, a new business dedicated to providing in-home support for seniors and families in the Round Rock, Georgetown, Leander, …

Oruka Therapeutics ·

Oruka Therapeutics Reports Positive Week 28 Data for ORKA-001

Oruka Therapeutics, a clinical-stage biotechnology company developing novel biologics for chronic skin diseases, announced positive Week 28 results from its EVERLAST-A Phase 2a trial of ORKA-001, a novel half-life extended IL-23p19 monoclonal antibody, in moderate-to-severe plaque psoriasis. The data showed …

Missouri Valley Regional Medical Center ·

Missouri Valley Regional Medical Center Rebranded to Reflect Commitment

MARSHALL, Mo. -- Missouri Valley Regional Medical Center, formerly known as Fitzgibbon Hospital, has unveiled a new name and identity as part of its ongoing commitment to serving the Marshall community and surrounding regions. This rebranding …

Lift Therapeutics ·

Lift Therapeutics Names Daniel Passeri as CEO

Lift Therapeutics, a biotechnology company pioneering a new class of immunotherapy for hard-to-treat cancers, has appointed Daniel Passeri as its Chief Executive Officer (CEO). Passeri brings over 30 years of experience in oncology and immunotherapy drug development, most recently serving …

Mölnlycke Health Care ·

New Report Reveals Opportunities to Expand Day Surgery

GOTHENBURG, Sweden -- Mölnlycke Health Care has released a new report, "The Hidden Capacity Report," which highlights the potential for expanding day surgery to improve healthcare efficiency and patient outcomes. The report, a collaborative effort involving …

Hyagen Medical ·

Hyagen Medical Discusses Regulatory Clarity in Stem Cell Therapy

Lehi, UT -- Hyagen Medical, a regenerative medicine company dedicated to advancing regulatory clarity, responsible education, and compliance in the human cellular and tissue-based products (HCT/P) sector, recently participated in the PepMed 2026 Regenerative Health World …

The American Academy of Allergy, Asthma & Immunology (AAAAI) ·

AAAAI Advocates for Penicillin Allergy De-labeling

MILWAUKEE -- September 28 marks National Penicillin Allergy Day, a day dedicated to raising awareness about the importance of accurately diagnosing and managing penicillin allergies. The American Academy of Allergy, Asthma & Immunology (AAAAI) is the …

Ossium Health ·

Ossium Health Tours Indianapolis Facility for Bone Marrow Bank

INDIANAPOLIS -- Ossium Health, a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening hematologic conditions and musculoskeletal defects, recently hosted U.S. Representative Erin …

ACU-Serve ·

ACU-Serve and Tennr Partner for Post-Acute Care Streamlining

AKRON, Ohio -- ACU-Serve, a leading provider of revenue cycle management solutions, has partnered with Tennr, the patient orchestration platform for specialty care, to revolutionize the front-end operations of post-acute care providers. This strategic alliance combines …

Clordisys Solutions, LLC ·

ClorDiSys Study Supports Chlorine Dioxide for Cold-Chain Sterilization

BRANCHBURG, N.J. -- A new peer-reviewed study published in PLOS ONE has demonstrated the capabilities of chlorine dioxide (ClO₂) gas sterilization as an ideal terminal sterilization option for temperature-sensitive pharmaceutical, medical device, and combination products.

Caracal Products & Services ·

Caracal Honors Mentorship with John Reumann Award

CHARLOTTE, N.C. -- Caracal Products & Services, a leading provider of health care solutions, recycling services, and distribution, has honored John Reumann with the Glen A. Taylor Excellence in Mentorship Award. The award, named for Glen …

Pinnacle Treatment Centers ·

Aegis Treatment Centers Expands Overdose Response Efforts

Canoga Park, CA -- Aegis Treatment Centers, part of the Pinnacle Treatment Centers Network, has been highlighted in a statewide spotlight through the H&SS (Hub & Spoke System) Program, which is funded by the California Department …

Conifer Health Solutions ·

Conifer Health Partners with NLA for Better Healthcare

DALLAS -- Conifer Health Solutions, a leading provider of specialized medical management services, has announced a strategic partnership with the National Labor Alliance of Health Care Coalitions (NLA). The partnership aims to reduce healthcare costs, improve …

Cadence Neuroscience ·

Cadence Neuroscience Names CEO for Clinical Trial Launch

REDMOND, Wash. -- Cadence Neuroscience, a clinical-stage company developing a biomarker-guided platform for personalized neuromodulation, has appointed Chris Cronin as its new Chief Executive Officer (CEO). The appointment comes as the company prepares for the clinical …

Vogenx, Inc ·

Vogenx Appoints Ken Toombs to Board

RALEIGH -- Vogenx, Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for serious metabolic and gastrointestinal diseases, has announced the appointment of Ken Toombs to its Board of Directors. Effective September 21, 2026, Toombs …

CurePSP ·

CurePSP Expands Care Network to Europe

NEW YORK -- CurePSP, the leading nonprofit organization dedicated to the awareness, care and cure for three neurodegenerative diseases: progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA), has expanded its prestigious Center …

TimelyCare ·

TimelyCare Study Reveals Early Improvements in Student Therapy

Fort Worth, TX -- A retrospective study analyzed 5,289 college students who entered virtual therapy reporting self-harm or suicidal ideation. Researchers found that 77.2% of students achieved initial remission of self-harm and suicidal ideation during the …

Medical Care Technologies Inc ·

Medical Care Technologies Inc. Completes First Collectibles Transaction

MESA, Ariz. -- Medical Care Technologies Inc., a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions, has announced that its subsidiaries, …

SK pharmteco ·

SK pharmteco expands rare disease manufacturing partnership for SMA treatment

RANCHO CORDOVA, Calif. -- SK pharmteco and GEMMABio have expanded their collaboration in rare disease manufacturing, following a significant milestone in a clinical trial for Spinal Muscular Atrophy (SMA) Type 1. The CHARISMA trial, which is …

TETmedical, Inc ·

TETmedical Appoints Industry Veterans to Board

FAIR HAVEN, N.J and ITHACA, N.Y. -- FAIR HAVEN, N.J and ITHACA, N.Y., Sept. 22, 2026 /CourierPR/ -- TETmedical, a clinical-stage medical diagnostics company developing rapid tools for diagnosing acute neurological injury, including ischemic stroke, based on its patented Tethered Enzyme Technology (TET), today announced the appointment …

Bevimi ·

Bevimi, RESOLV Partner to Improve Veteran Brain Health

GREENWICH, Conn. -- Bevimi and RESOLV Proving Ground have announced a strategic partnership aimed at improving the brain health and performance of Special Operations Veterans. The collaboration will combine RESOLV’s proven training methods with Bevimi’s scientifically …

Propanc Biopharma, Inc ·

Propanc Biopharma Compares PRP to Erasca’s ERAS-0015 in Pancreatic Cancer Treatment

MELBOURNE, Australia -- Propanc Biopharma, Inc., a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, has released a comparative analysis of its lead candidate PRP against Erasca, Inc.’s pan-RAS …

SAB Biotherapeutics, Inc ·

SAB Biotherapeutics to Present SAB-142 Data at EASD Conference

MIAMI -- SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced presentations at the upcoming 62nd Annual Meeting …

MAIA Biotechnology, Inc ·

MAIA Biotech Reports Phase 3 Trial Milestone in Lung Cancer Treatment

CHICAGO -- MAIA Biotechnology, Inc., a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, has announced significant progress in its ongoing pivotal Phase 3 clinical trial, THIO-104, evaluating its novel telomere-targeting therapy as a …

Polyrizon Ltd ·

Polyrizon Begins U.S. Clinical Study of Allergy Blocker

Raanana, Israel -- Polyrizon Ltd., a clinical-stage biotech company specializing in the development of innovative intranasal hydrogels, has announced the enrollment of the first patient in its U.S. clinical study to evaluate NASARIX (PL-14), the company’s …

Envoy Medical, Inc ·

Envoy Medical Expands Patent Portfolio Globally

Envoy Medical® Inc., a hearing health company pioneering fully implanted hearing solutions, today announced the grant of two additional international patents, expanding its global intellectual property portfolio to 97 patents. This portfolio consists of 40 U.S. and 57 foreign patents.

Eos SENOLYTIX, Inc ·

Eos SENOLYTIX to Present at Mitochondria Conference

HOUSTON -- Eos SENOLYTIX, Inc., a biotechnology company focused on developing first-in-class gerotherapeutic peptide medicines that target the underlying biological mechanisms of aging, announced its participation at the 17th World Congress on Targeting Mitochondria 2026, which …

Aardvark Therapeutics, Inc. (NASDAQ: AARD) ·

Investors Sidelined as Companies Face Regulatory Scrutiny

PHILADELPHIA -- Aardvark Therapeutics, Inc. (NASDAQ: AARD) has faced significant setbacks following its initial public offering (IPO) on February 13, 2025. The company's lead drug candidate, ARD-101, has been the subject of intense scrutiny following the …

Iterion Therapeutics ·

Iterion Therapeutics Shows Promising Data for Tegavivint Combo Therapy in Lung Cancer Patients

HOUSTON -- Iterion Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing the treatment of Wnt-driven cancers, today announced promising results from an investigator-sponsored Phase 1b study evaluating tegavivint in combination with osimertinib as first-line therapy for …

PDS Biotech ·

PDS Biotech Trial Shows Promise for HPV16-Positive Cancer Patients

PRINCETON, N.J. -- PDS Biotechnology Corporation, a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, has announced the publication of results from a Phase 2 trial evaluating its HPV16-targeted immunotherapy, …

IMUNON ·

IMUNON Recommends Continued MRD Study for IMNN-001 Immunotherapy

LAWRENCEVILLE, N.J. -- The Independent Data Monitoring Committee (IDMC) overseeing IMUNON's ongoing Phase 2 minimal residual disease (MRD) translational study of IMNN-001 has recommended that the study continue without modification. The IDMC reviewed all safety data …

CervoMed Inc ·

CervoMed to Participate in Healthcare Conference

BOSTON -- CervoMed Inc., a clinical-stage company focused on developing treatments for age-related neurologic disorders, announced today that its management team will participate in a panel discussion and one-on-one meetings at the upcoming 5th Annual ROTH …

Lymphatic Malformation Alliance ·

Lymphatic Malformation Alliance meets FDA to seek new treatments

SAINT PETERSBURG, Fla. -- The Lymphatic Malformation Alliance (LMA) has met with senior leaders at the U.S. Food and Drug Administration (FDA) to raise awareness of lymphatic malformations (LMs) and the urgent need for safe and …

Zenas BioPharma ·

Zenas Announces Obexelimab Data at Rheumatology Conferences

WALTHAM, Mass. -- Zenas BioPharma, a clinical-stage global biopharmaceutical company focused on the development and commercialization of therapies for autoimmune diseases and inflammatory conditions, announced new data from the Phase 3 INDIGO trial evaluating obexelimab in …

WELL Health Technologies Corp ·

WELL Health Launches Clinical Research Platform

WELL Health Technologies Corp., a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, has announced the launch of WELL Research, its consolidated clinical research brand. WELL Research offers …

Talk to the desk

Questions before you file?

Volume pricing, corrections, partnerships — whatever doesn't fit a form field. Tell us what you need and we'll size it properly.

Contact us